CNTB
CNTB
NASDAQ · Biotechnology

Connect Biopharma Holdings L

$0.70
+0.01 (+1.44%)
As of Nov 12, 2:42 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +2,842.2% upside
Low Target $15.18
Average Target $20.56
High Target $23.56
Current Price $0.70
Current
$0.70
Target
$20.56
$15.18 $20.56 avg $23.56
Scenario Analysis
Bear Case
$15.18
2,072.3%
Low target
Base Case
$20.56
+2,842.2%
Avg target
Bull Case
$23.56
+3,271.5%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$3.82
-81.7% from high
52-Week Low
$0.71
+-1.6% from low
Target vs 52W High
$20.56
+438.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%